期刊文献+

来氟米特对类风湿关节炎患者Th17细胞免疫调节的影响 被引量:3

Immunoregulation effects of leflunomide on Th17 cells in peripheral blood of rheumatoid arthritis in vitro
下载PDF
导出
摘要 目的:探讨来氟米特活性代谢产物A771726对类风湿关节炎(RA)患者外周血Th17细胞的影响及意义。方法:取RA患者外周血单个核细胞(PBMC),采用免疫磁珠法阴选出CD4+T辅助细胞(helper T cell,Th),将CD4+T细胞分别与不同剂量的A771726(15、30、60μg/ml)和地塞米松(10-6、10-7、10-8mol/L)共培养48 h,流式细胞术(FCM)检测RA患者外周血Th17/Th百分比;应用实时荧光定量逆转录聚合酶链技术(即RT-PCR)检测IL-17、ROR-γt mRNA水平。结果:在体外,来氟米特对RA患者外周血CD4+T细胞胞内IL-17、ROR-γt mRNA表达无明显抑制作用,地塞米松可以使CD4+T细胞胞内IL-17、ROR-γt mRNA表达明显减少,随着药物浓度的增加抑制作用更加明显。来氟米特对Th17/Th无明显影响,地塞米松能降低Th17/Th细胞百分比。结论:来氟米特对RA患者外周血Th17细胞无明显影响作用,而地塞米松则可显著降低Th17细胞在Th细胞中的比例。 Objective: To investigate the effect and significance of A771726(activated metabolite of leflunomide) and dexamethasone on the expression of Th17 cells in patients with rheumatoid arthritis(RA).Methods: Isolatating CD4+T cells from PBMC by magnetic cell separator and then cultured with A771726(concentration respectively as 15,30,60 μg/ml) or dexamethasone(concentration respectively as 10-6,10-7,10-8mol/L) for 48 hours.Determination of the percentage of Th17/Th by flow cytometry.The expression level of IL-17 and ROR-γt mRNA was determined by RT-PCR.Results: There was no obvious effect of leflunomide on intracellular IL-17 or ROR-γt mRNA of CD4+ T cells.The expression level of intracellular IL-17 and ROR-γt mRNA on CD4+ T cells were reduced by dexamethasone and these effect were more obvious with the increase of drug concentration.Leflunomide had no obvious effect on the percentage of Th17 cells,but dexamethasone could decrease the percentage of Th17 cells. Conclusion: Leflunomide had no obvious effect on Th17 cells,but dexamethasone could evidently decrease the percentage of Th17 cells.
出处 《江苏大学学报(医学版)》 CAS 2012年第1期24-26,30,共4页 Journal of Jiangsu University:Medicine Edition
基金 国家自然科学基金资助项目(30872335) 江苏大学校内基金资助项目(20080008)
关键词 类风湿关节炎 地塞米松 来氟米特 A771726 IL-17 ROR-γt rheumatoid arthritis dexamethasone leflunomide A771726 IL-17 ROR-γt
  • 相关文献

参考文献9

  • 1Park H,Li Z,Yang XO,et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin17[J].Nat Immunol,2005,6(11):1133-1141.
  • 2Harrington LE,Hatton RD,Mangan PR,et al Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol,2005,6(11):1123-1132.
  • 3Pernis AB.Th17 cells in rheumatoid arthritis and systemic lupus erythematosus[J].J Intern Med,2009,265(6):644-652.
  • 4Van Roon EN,Hoekstra M,Tobi H,et al.Leflunomide in the treatment of rheumatoid arthritis.Ananalysis of predictors for treatment continuation[J].Br J Clin Pharmacol,2005,60(3):319 325.
  • 5Buttgereit F,Straub RH,Wehling M,et al.Glucocorticoids in the treatment of rheumatic diseases:An update on the mechanisms of action[J].Arthritis Rheum,2004,50(11):3408-3417.
  • 6Lubberts E,Joosten LA,van de Loo FA,et al.Reduction of interleukin-17-induced inhibition of chondrocyte proteogly can synthesis in intact murine articular cartilage by interleukin-4[J].Arthritis Rheum,2000,43(6):1300-1306.
  • 7Kellner H,Bornholdt K,Hein G,et al.Leflunomide in the treatment of patients with early rheumatoid arthritis-results of a prospective non-interventional study[J].Clin Rheumatol,2010,29(8):913-920.
  • 8Wang HY,Cui TG,Hou FF,et al.Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone:a prospective multicentre observational study[J].Lupus,2008,17(7):638-644.
  • 9Fukushima R,Kanamori S,Hirashiba M,et al.Inhibiting the teratogenicity of the immuno suppressant lefunomide in mice by supplementation of exogenous uridine[J].Toxicol Sci,2009,108(2):419-426.

同被引文献37

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部